Impact of TrumpRx and DTC Programs on Drug Availability
Jesse Mendelsohn, executive vice president at Model N, discusses the effects of selling drugs directly to patients.
Anything that expands access to pharmaceutical manufacturing and drugs is good.
According to Mendelsohn, even if TrumpRx and other DTC programs only provide access to lifesaving drugs for several thousand people, it is a positive development.
- Most people with insurance coverage, including Medicaid or private insurance, will continue to receive their medications through traditional channels.
- The programs may not significantly expand access to drugs for the majority of people.
Mendelsohn notes that for most individuals, the way they obtain prescribed medications will not change.
Author's summary: TrumpRx may slightly expand drug access.
More News
- Best Esports Betting Sites in 2025 - Top Bookmakers, Tips & Offers
- Chicago Catholics confront ICE, fear and protests to protect migrants' dignity, religious rights - Catholic Standard
- "She Could Fly": Al Pacino's Heartfelt Tribute to Co-Star and Ex-Partner Diane Keaton
- Suspect in Kada Scott disappearance seen peering into woman's window in viral video: sources
- Israeli airstrikes killed 1 and injured 7 in Lebanon despite ceasefire – Ya Libnan
- Vampire: The Masquerade – Bloodlines 2 Should've Released 20 Years Ago Because It's Stuck in the PS2 Era (Review)
- Creating a City & Guilds fit for the fourth industrial revolution
- Mentone Town Council Adopts 2026 Budget
- Suspect in Kada Scott disappearance seen peering into woman's window in viral TikTok: sources
- Palestine Protestors Disrupt Brian O'Driscoll Speech At Cybertech Event | Balls.ie